نتایج جستجو برای: hemostatic agent
تعداد نتایج: 264645 فیلتر نتایج به سال:
Although, Ankaferd hemostat (Ankaferd Blood Stopper, ABS) could be utilized successfully as hemostatic agent, studies demonstrated that it has cytotoxic effects on cells. However, the mechanism(s) of this effect has not been elucidated yet. In this study, cytotoxic, genotoxic, apoptotic and reactive oxygen generating (ROS) activities of ABS were investigated in melanoma and normal cell lines. T...
Ankaferd Bloodstopper (ABS) which is a medicinal product has been approved in the control of hemorrhage externally, dental surgery bleedings in Turkey to control the bleeding in renal trauma model was evaluated. Twelve Wistar rats were divided into two groups. Group I (GI),control, Group II (GII), study group. One cm2 tissue was resected. ABS solution was applied to resected area in study group...
In the current report, interaction of Al-doped carbon nanotubes (CNT) with carbazochrome, an anti-hemorrhagic or hemostatic agent, was investigated M06-2X functional and 6-31G* basis set. The global index including frontier molecular orbital energies, hardness, softness, chemical Gibbs energies some parameters NLO properties Carbazochrome, Al doped CNT complexes formed between their were calcul...
Topical hemostatic agents are utilized as adjuncts to control intraoperative bleeding when standard surgical techniques (such as suturing, ligature, cautery, or pressure) are insufficient or impractical to implement1. Intraoperative scenarios where topical hemostatic agents may serve as adjuncts include bleeding near vital organs or nerves, at needle-holes, from raw surface areas, in friable or...
AIM Ankaferd Blood Stopper (ABS), as an herbal complementary medicine, has been approved for the management of clinical hemorrhages in Turkey, including dental interventions. Basic, preclinical and clinical studies disclosed the settings of the topical hemostatic use of ABS. The aim of this study is therefore to assess the efficacy and safety of ABS as an antihemorrhagic agent in the bleedings ...
The majority (~80%) of hemorrhagic deaths on the battlefield are due to intracavitary hemorrhage that is not accessible for direct compression and cannot be treated with externally applied hemostatic agents. In an attempt to address this issue, a project was initiated to evaluate the efficacy of different hemostatic products when introduced into a closed hemorrhaging body cavity. Two thrombin-b...
The use of fibrinolytic agents to prevent new thrombus formation is limited by an increased risk of bleeding due to lysis of hemostatic clots that prevent hemorrhage in damaged blood vessels. We sought to develop an agent that provides thromboprophylaxis without carrying a significant risk of causing systemic fibrinolysis or disrupting hemostatic clots. We previously showed that platelet (PLT) ...
Hemorrhage control is often a problem for the clinician during osseous surgery. Ferric sulfate is an effective hemostatic agent, but with prolonged application to an osseous defect can cause persistent inflammation and delayed healing. The purpose of this investigation was to evaluate the effectiveness of ferric sulfate as a hemostatic agent and to determine its effect on healing after thorough...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید